mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.01 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.01 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.01 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.01 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.02 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.02 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.02 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.02 |
mRNA |
JNK Inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.086 |
0.02 |